The FDA granted marketing authorization for the Sepsis ImmunoScore, an artificial intelligence (AI) software tool for rapid diagnosis and risk assessment of sepsis, Prenosis announced Wednesday.
The health technology company Prenosis on Wednesday announced its artificial intelligence-powered diagnostic tool for sepsis is the first to receive approval from the U.S. Food and Drug Administration ...
Health technology innovator Prenosis has achieved a life-changing milestone with the U.S. Food and Drug Administration (FDA) granting approval to its groundbreaking AI-powered diagnostic tool for ...
ST. LOUIS, June 28, 2024 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) authorized a new tool called Sepsis ImmunoScore™, created by Prenosis, Inc. This tool uses artificial intelligence ...
The FDA has authorized the nation’s first AI-powered sepsis detection tool, artificial intelligence company Prenosis said April 3. Clinicians have long been searching for — and testing — detection ...
The Sepsis ImmunoScore™ is the first-ever AI Sepsis Diagnostic granted marketing authorization by the FDA. CHICAGO, April 3, 2024 /PRNewswire/ -- Prenosis, Inc., an artificial intelligence company ...
Groundbreaking NEJM AI Study Highlights the Ability of Prenosis' Sepsis ImmunoScore™ to Holistically Predict Adverse Outcomes, Ushering in a New Era of Predictive Sepsis Tools Powered by AI CHICAGO, ...
A new sepsis prediction score was used in 77% of patients during out-of-hours GP visits in Netherlands, with 85% usage seen in acutely ill patients. GPs found the score convenient, with 93% rating it ...
Sepsis is a disease that is deadly and still somewhat of a mystery. At UC San Diego, doctors and med-tech engineers are trying to crack the code with new diagnostic techniques and artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results